Advertisement

Monocytic Sarcoma

  • Roberto N. Miranda
  • Joseph D. Khoury
  • L. Jeffrey Medeiros
Chapter
Part of the Atlas of Anatomic Pathology book series (AAP)

Abstract

Monocytic sarcoma is an extramedullary tumor mass composed of monocytic or myelomonocytic blasts with or without maturation. Many clinical features of patients with monocytic sarcoma mirror those of patients with granulocytic sarcoma (the reader is referred to the previous chapter). Most patients affected with monocytic sarcoma are adults, and the median age is in the sixth decade of life.

Monocytic sarcomas have a pronounced tendency to involve skin. Other frequently affected sites are lymph node, gastrointestinal tract, and soft tissue. Most cases of monocytic sarcoma occur in patients with acute myeloid leukemia (AML) falling in the French–American–British (FAB) categories M4 or M5, but there are reports of monocytic sarcoma associated with several categories of AML in the current World Health Organization (WHO) classification.

Keywords

Acute Myeloid Leukemia Plasmacytoid Dendritic Cell Granulocytic Sarcoma Immunophenotypic Analysis Blastic Plasmacytoid Dendritic Cell Neoplasm 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Bueso-Ramos CE. Myeloid/monocytic sarcoma. In: Medeiros LJ, editor. Diagnostic pathology: lymph nodes and spleen with extranodal lymphomas. 1st ed. Altona: Amirsys, Inc; 2011. p. 13-2–9.Google Scholar
  2. 2.
    Elenitoba-Johnson K, Hodges GF, King TC, Wu CD, Medeiros LJ. Extramedullary myeloid cell tumors arising in the setting of chronic myelomonocytic leukemia. A report of two cases. Arch Pathol Lab Med. 1996;120:62–7.PubMedGoogle Scholar
  3. 3.
    Chang H, Brandwein J, Yi QL, Chun K, Patterson B, Brien B. Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome. Leuk Res. 2004;28:1007–11.PubMedCrossRefGoogle Scholar
  4. 4.
    Johansson B, Fioretos T, Kullendorff CM, et al. Granulocytic sarcomas in body cavities in childhood acute myeloid leukemias with 11q23/MLL rearrangements. Genes Chromosomes Cancer. 2000;27:136–42.PubMedCrossRefGoogle Scholar
  5. 5.
    Pileri SA, Ascani S, Cox MC, et al. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia. 2007;21:340–50.PubMedCrossRefGoogle Scholar
  6. 6.
    Roth MJ, Medeiros LJ, Elenitoba-Johnson K, Kuchnio M, Jaffe ES, Stetler-Stevenson M. Extramedullary myeloid cell tumors. An immunohistochemical study of 29 cases using routinely fixed and processed paraffin-embedded tissue sections. Arch Pathol Lab Med. 1995;119:790–8.PubMedGoogle Scholar
  7. 7.
    Slomowitz SJ, Shami PJ. Management of extramedullary leukemia as a presentation of acute myeloid leukemia. J Natl Compr Canc Netw. 2012;10:1165–9.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Roberto N. Miranda
    • 1
  • Joseph D. Khoury
    • 1
  • L. Jeffrey Medeiros
    • 1
  1. 1.Department of HematopathologyThe University of Texas M.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations